David Raben Bicara Therapeutics Inc. (BCAX) insider trading activity

BCAX Quotes by TradingView
Shares Held (Direct Ownership) 55.3K
55.75% 3M change
n/a 12M change
Total Value Held N/A

David Raben Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 26 2025
BUY
Exercise of conversion of derivative security
$75,000 $3.79 p/Share
19,789 Added 26.36%
55,286 Common Stock
Nov 25 2025
SELL
Open market or private sale
$103,620 $18.84 p/Share
5,500 Reduced 13.42%
35,497 Common Stock
Nov 25 2025
BUY
Exercise of conversion of derivative security
$20,845 $3.79 p/Share
5,500 Added 13.13%
36,403 Common Stock
Nov 24 2025
SELL
Open market or private sale
$101,475 $18.45 p/Share
5,500 Reduced 13.42%
35,497 Common Stock
Nov 24 2025
BUY
Exercise of conversion of derivative security
$20,845 $3.79 p/Share
5,500 Added 11.83%
40,997 Common Stock
Oct 09 2025
SELL
Open market or private sale
$405,900 $18.45 p/Share
22,000 Reduced 38.26%
35,497 Common Stock
Oct 09 2025
BUY
Exercise of conversion of derivative security
$83,380 $3.79 p/Share
22,000 Added 27.67%
57,497 Common Stock
DR

David Raben

Chief Medical Officer
Boston, MA

Track Institutional and Insider Activities on BCAX

Follow Bicara Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCAX shares.

Notify only if

Insider Trading

Get notified when an Bicara Therapeutics Inc. insider buys or sells BCAX shares.

Notify only if

News

Receive news related to Bicara Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCAX